Neurotensin induces tyrosine hydroxylase gene activation through nitric oxide and protein kinase C signaling pathways.
暂无分享,去创建一个
J. Mallet | P. Forgez | W. Rostène | M. Najimi | J. Robert
[1] W. Rostène,et al. Neurotensin: an endogenous psychostimulant? , 2002, Current opinion in pharmacology.
[2] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[3] Jesse D. Martinez,et al. Bile Acid-induced Activation of Activator Protein-1 Requires Both Extracellular Signal-regulated Kinase and Protein Kinase C Signaling* , 2000, The Journal of Biological Chemistry.
[4] W. Willis,et al. Fos expression is induced by increased nitric oxide release in rat spinal cord dorsal horn , 2000, Neuroscience.
[5] J. Bressler,et al. Increased AP‐1 DNA Binding Activity in PC12 Cells Treated with Lead , 1999, Journal of neurochemistry.
[6] G. Boss,et al. Nitric Oxide Regulation of Gene Transcription via Soluble Guanylate Cyclase and Type I cGMP-dependent Protein Kinase* , 1999, The Journal of Biological Chemistry.
[7] M. Besson,et al. Glutamate Induces Phosphorylation of Elk-1 and CREB, Along with c-fos Activation, via an Extracellular Signal-Regulated Kinase-Dependent Pathway in Brain Slices , 1999, Molecular and Cellular Biology.
[8] R. Spanagel,et al. Repeated Administration of the Neurotensin Receptor Antagonist SR 48692 Differentially Regulates Mesocortical and Mesolimbic Dopaminergic Systems , 1998, Journal of neurochemistry.
[9] P. Forgez,et al. Activation of Receptor Gene Transcription Is Required to Maintain Cell Sensitization after Agonist Exposure , 1998, The Journal of Biological Chemistry.
[10] C. Alling,et al. Stimulation of Muscarinic Receptors Induces Expression of Individual fos and jun Genes Through Different Transduction Pathways , 1998, Journal of neurochemistry.
[11] J. Haycock. Short‐ and Long‐Term Regulation of Tyrosine Hydroxylase in Chromaffin Cells by VIP and PACAP a , 1996, Annals of the New York Academy of Sciences.
[12] C. Kilts,et al. Neurotensin induces Fos and Zif268 expression in limbic nuclei of the rat brain , 1996, Neuroscience.
[13] P. Forgez,et al. Quantitative RT-PCR: limits and accuracy. , 1996, BioTechniques.
[14] K. Vrana,et al. Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression , 1996, Journal of neurochemistry.
[15] B. Spiegelman,et al. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. , 1996, Oncogene.
[16] J. Mallet. The TiPS/TINS lecture. Catecholamines: from gene regulation to neuropsychiatric disorders. , 1996, Trends in pharmacological sciences.
[17] T. Joh,et al. AP1‐Mediated Transcriptional Enhancement of the Rat Tyrosine Hydroxylase Gene by Muscarinic Stimulation , 1996, Journal of neurochemistry.
[18] L. Ignarro,et al. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA. , 1994, Molecular pharmacology.
[19] D. Gully,et al. Increase in neurotensin receptor expression in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692 , 1994, Neuroscience Letters.
[20] K. Pennypacker,et al. Pharmacological regulation of AP‐1 transcription factor DNA binding activity 1 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] D. Gully,et al. SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures. , 1994, European journal of pharmacology.
[22] M. Therrien,et al. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene , 1993, Molecular and cellular biology.
[23] S. Berry,et al. Evidence for protein kinase-C mediation of the neurotensin-induced activation of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons. , 1992, Endocrinology.
[24] E. Richelson,et al. Developmental regulation of neurotensin receptor expression and function in murine neuroblastoma clone N1E-115. , 1991, European journal of pharmacology.
[25] J. Mallet,et al. Transcriptional and post‐transcriptional regulation of tyrosine hydroxylase gene by protein kinase C. , 1990, The EMBO journal.
[26] Masayuki Masu,et al. Structure and functional expression of the cloned rat neurotensin receptor , 1990, Neuron.
[27] M. Stachowiak,et al. Short and long term regulation of catecholamine biosynthetic enzymes by angiotensin in cultured adrenal medullary cells. Molecular mechanisms and nature of second messenger systems. , 1990, The Journal of biological chemistry.
[28] P. Kitabgi,et al. Neurotensin, bradykinin and somatostatin inhibit cAMP production in neuroblastoma N1E115 cells via both pertussis toxin sensitive and insensitive mechanisms. , 1989, Biochemical and biophysical research communications.
[29] M. Yaniv,et al. Characterization of junD: a new member of the jun proto‐oncogene family. , 1989, The EMBO journal.
[30] I. Verma,et al. fos-associated cellular p39 is related to nuclear transcription factor AP-1 , 1988, Cell.
[31] E. Richelson,et al. Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115. , 1988, Biochemical pharmacology.
[32] P. Kitabgi,et al. Stimulation of Inositol Phosphate Production by Neurotensin in Neuroblastoma N1E115 Cells: Implication of GTP‐Binding Proteins and Relationship with the Cyclic GMP Response , 1987, Journal of neurochemistry.
[33] T. Hökfelt,et al. Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons , 1984, The Journal of comparative neurology.
[34] M. Bräutigam,et al. Mouse neuroblastoma clone N1E-115: a suitable model for studying the action of dopamine agonists of tyrosine hydroxylase activity. , 1982, Biochemical pharmacology.
[35] E. Richelson,et al. REGULATION OF TYROSINE HYDROXYLASE ACTIVITY IN MOUSE NEUROBLASTOMA CLONE N1E‐115 , 1973, Journal of neurochemistry.
[36] S. Udenfriend,et al. TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.
[37] P. Kitabgi,et al. Reduced peptide bond pseudopeptide analogues of neurotensin. , 1992, Peptide research.
[38] A. Beaudet,et al. Correspondence between high affinity 125I‐neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: A combined radioautographic and immunohistochemical light microscopic study , 1989, The Journal of comparative neurology.